Key Points
- Director Jeri Williams sold 157 shares on March 17 at an average price of $490 for a total of $76,930, trimming her stake by 11.93% to 1,159 shares (worth about $567,910).
- Axon beat quarterly expectations, reporting $2.15 EPS vs. $1.60 expected and $796.72 million revenue vs. $755.29 million expected, with revenue up 38.5% year-over-year.
- Analyst sentiment is broadly positive, with a "Moderate Buy" consensus (16 Buys, 3 Holds) and an average price target of $762.93.
Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) Director Jeri Williams sold 157 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total transaction of $76,930.00. Following the sale, the director owned 1,159 shares of the company's stock, valued at approximately $567,910. The trade was a 11.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Axon Enterprise Price Performance
Shares of AXON stock opened at $489.94 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The company has a market capitalization of $39.39 billion, a PE ratio of 323.27, a price-to-earnings-growth ratio of 10.85 and a beta of 1.46. The firm's 50-day moving average is $522.19 and its two-hundred day moving average is $603.07. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts' expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business's revenue for the quarter was up 38.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.08 EPS. Analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.
Hedge Funds Weigh In On Axon Enterprise
Institutional investors have recently modified their holdings of the business. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at $28,000. Stone House Investment Management LLC purchased a new position in Axon Enterprise in the third quarter valued at $29,000. New Millennium Group LLC acquired a new position in Axon Enterprise during the 3rd quarter worth $29,000. Sound Income Strategies LLC grew its stake in Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company's stock worth $30,000 after purchasing an additional 44 shares in the last quarter. Finally, Camelot Portfolios LLC purchased a new stake in Axon Enterprise during the 4th quarter worth about $30,000. Institutional investors and hedge funds own 79.08% of the company's stock.
Analyst Ratings Changes
Several analysts recently weighed in on the stock. Citigroup reiterated a "buy" rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Wall Street Zen upgraded Axon Enterprise from a "sell" rating to a "hold" rating in a research report on Saturday, February 28th. William Blair reaffirmed an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a report on Wednesday, February 25th. Finally, Morgan Stanley lowered their target price on Axon Enterprise from $713.00 to $675.00 and set an "overweight" rating for the company in a report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $762.93.
Check Out Our Latest Research Report on Axon Enterprise
Axon Enterprise Company Profile
(
Get Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
